Teva Pharmaceutical Industries - stock earnings
TEVA Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 8, 2024 BeforeMarket | - / 0.5100000000 | - | - / 3.7 billion | - |
TEVA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 429.0 million USD | 4.5 billion USD |
| 2023Q3 | 80.0 million USD | 3.9 billion USD |
| 2023Q2 | -863.0 million USD | 3.9 billion USD |
| 2023Q1 | -205.0 million USD | 3.7 billion USD |
| 2022Q4 | -1.2 billion USD | 3.9 billion USD |
| 2022Q3 | 56.0 million USD | 3.6 billion USD |
| 2022Q2 | -232.0 million USD | 3.8 billion USD |
| 2022Q1 | -955.0 million USD | 3.7 billion USD |
| 2021Q4 | -159.0 million USD | 4.1 billion USD |
| 2021Q3 | 292.0 million USD | 3.9 billion USD |
| 2021Q2 | 207.0 million USD | 3.9 billion USD |
| 2021Q1 | 77.0 million USD | 4.0 billion USD |
| 2020Q4 | 150.0 million USD | 4.5 billion USD |
| 2020Q3 | -4.3 billion USD | 4.0 billion USD |
| 2020Q2 | 140.0 million USD | 3.9 billion USD |
| 2020Q1 | 69.0 million USD | 4.4 billion USD |
| 2019Q4 | 110.0 million USD | 4.5 billion USD |
| 2019Q3 | -314.0 million USD | 4.3 billion USD |
| 2019Q2 | -689.0 million USD | 4.3 billion USD |
| 2019Q1 | -105.0 million USD | 4.3 billion USD |
| 2018Q4 | -2.9 billion USD | 4.6 billion USD |
| 2018Q3 | -208.0 million USD | 4.5 billion USD |
| 2018Q2 | -176.0 million USD | 4.7 billion USD |
| 2018Q1 | 1.1 billion USD | 5.1 billion USD |
| 2017Q4 | -11.5 billion USD | 5.5 billion USD |
| 2017Q3 | 595.0 million USD | 5.6 billion USD |
| 2017Q2 | -6.0 billion USD | 5.7 billion USD |
| 2017Q1 | 645.0 million USD | 5.6 billion USD |
| 2016Q4 | -973.0 million USD | 6.5 billion USD |
| 2016Q3 | 412.0 million USD | 5.6 billion USD |
| 2016Q2 | 254.0 million USD | 5.0 billion USD |
| 2016Q1 | 636.0 million USD | 4.8 billion USD |
| 2015Q4 | 500.0 million USD | 4.9 billion USD |
| 2015Q3 | 103.0 million USD | 4.8 billion USD |
| 2015Q2 | 539.0 million USD | 5.0 billion USD |
| 2015Q1 | 446.0 million USD | 5.0 billion USD |
| 2014Q4 | 687.0 million USD | 5.2 billion USD |
| 2014Q3 | 876.0 million USD | 5.1 billion USD |
| 2014Q2 | 748.0 million USD | 5.0 billion USD |
| 2014Q1 | 744.0 million USD | 5.0 billion USD |
| 2013Q4 | 380.0 million USD | 5.4 billion USD |
| 2013Q3 | 711.0 million USD | 5.1 billion USD |
| 2013Q2 | -452.0 million USD | 4.9 billion USD |
| 2013Q1 | 630.0 million USD | 4.9 billion USD |
| 2012Q4 | 320.0 million USD | 5.2 billion USD |
| 2012Q3 | -79.0 million USD | 5.0 billion USD |
| 2012Q2 | 863.0 million USD | 5.0 billion USD |
| 2012Q1 | 859.0 million USD | 5.1 billion USD |
| 2011Q4 | 506.0 million USD | 5.7 billion USD |
| 2011Q3 | 916.0 million USD | 4.3 billion USD |
| 2011Q2 | 576.0 million USD | 4.2 billion USD |
| 2011Q1 | 761.0 million USD | 4.1 billion USD |
| 2010Q4 | 771.0 million USD | 4.4 billion USD |
| 2010Q3 | 1.1 billion USD | 4.3 billion USD |
| 2010Q2 | 797.0 million USD | 3.8 billion USD |
| 2010Q1 | 713.0 million USD | 3.7 billion USD |
| 2009Q4 | 379.0 million USD | 3.8 billion USD |
| 2009Q3 | 649.0 million USD | 3.6 billion USD |
| 2009Q2 | 523.0 million USD | 3.4 billion USD |
| 2009Q1 | 451.0 million USD | 3.1 billion USD |
| 2008Q4 | -688.0 million USD | 2.8 billion USD |
| 2008Q3 | 637.0 million USD | 2.8 billion USD |
| 2008Q2 | 539.0 million USD | 2.8 billion USD |
| 2008Q1 | 147.0 million USD | 2.6 billion USD |
| 2007Q4 | 570.0 million USD | 2.6 billion USD |
| 2007Q3 | 525.0 million USD | 2.4 billion USD |
| 2007Q2 | 515.0 million USD | 2.4 billion USD |
| 2007Q1 | 342.0 million USD | 2.1 billion USD |
| 2006Q4 | 459.9 million USD | 2.3 billion USD |
| 2006Q3 | 606.4 million USD | 2.3 billion USD |
| 2006Q2 | 488.4 million USD | 2.2 billion USD |
| 2006Q1 | -1.0 billion USD | 1.7 billion USD |
| 2005Q4 | 304.9 million USD | 1.4 billion USD |
| 2005Q3 | 267.1 million USD | 1.3 billion USD |
| 2005Q2 | 241.2 million USD | 1.2 billion USD |
| 2005Q1 | 259.1 million USD | 1.3 billion USD |
| 2004Q4 | 278.8 million USD | 1.3 billion USD |
| 2004Q3 | 251.5 million USD | 1.2 billion USD |
| 2004Q2 | 229.5 million USD | 1.2 billion USD |
| 2004Q1 | -428.0 million USD | 1.1 billion USD |
| 2003Q4 | 186.3 million USD | 942.0 million USD |
| 2003Q3 | 156.6 million USD | 812.6 million USD |
| 2003Q2 | 210.4 million USD | 764.4 million USD |
| 2003Q1 | 137.7 million USD | 757.4 million USD |
| 2002Q4 | 136.5 million USD | 770.2 million USD |
| 2002Q3 | 96.3 million USD | 631.3 million USD |
| 2002Q2 | 91.9 million USD | 572.0 million USD |
| 2002Q1 | 85.6 million USD | 545.1 million USD |
| 2001Q4 | 79.6 million USD | 567.1 million USD |
| 2001Q3 | 79.4 million USD | 505.7 million USD |
| 2001Q2 | 64.4 million USD | 513.6 million USD |
| 2001Q1 | 54.8 million USD | 490.9 million USD |
| 2000Q4 | 55.0 million USD | 518.5 million USD |
| 2000Q3 | 46.6 million USD | 450.1 million USD |
| 2000Q2 | 9.0 million USD | 444.0 million USD |
| 2000Q1 | 37.9 million USD | 337.3 million USD |
| 1999Q4 | 40.0 million USD | 379.9 million USD |
| 1999Q3 | 18.4 million USD | 321.1 million USD |
| 1999Q2 | 31.1 million USD | 293.7 million USD |
| 1999Q1 | 28.3 million USD | 287.6 million USD |
| 1998Q4 | 1.4 million USD | 296.9 million USD |
| 1998Q3 | 25.3 million USD | 303.3 million USD |
| 1998Q2 | 17.1 million USD | 247.1 million USD |
| 1998Q1 | 25.1 million USD | 268.6 million USD |
| 1997Q4 | 300000 USD | 291.9 million USD |
| 1997Q3 | 35.8 million USD | 286.7 million USD |
| 1997Q2 | 34.0 million USD | 270.7 million USD |
| 1997Q1 | 31.5 million USD | 267.6 million USD |
| 1996Q4 | 30.2 million USD | 277.7 million USD |
| 1996Q3 | 23.9 million USD | 236.6 million USD |
| 1996Q2 | -3.0 million USD | 250.2 million USD |
| 1996Q1 | 22.3 million USD | 189.3 million USD |
| 1995Q4 | 19.8 million USD | 192.9 million USD |
| 1995Q3 | 21.6 million USD | 165.3 million USD |
| 1995Q2 | 19.5 million USD | 156.8 million USD |
| 1995Q1 | 18.9 million USD | 152.7 million USD |
| 1994Q4 | 18.9 million USD | 160.6 million USD |
| 1994Q3 | 17.5 million USD | 143.5 million USD |
| 1994Q2 | 18.2 million USD | 146.9 million USD |
| 1994Q1 | 17.1 million USD | 136.7 million USD |
| 1993Q4 | 16.2 million USD | 131.3 million USD |
| 1993Q3 | 13.9 million USD | 127.2 million USD |
| 1993Q2 | 13.9 million USD | 125.0 million USD |
| 1993Q1 | 13.5 million USD | 118.4 million USD |
| 1992Q4 | 11.5 million USD | 131.9 million USD |
| 1992Q3 | 6.7 million USD | 93.0 million USD |
| 1992Q2 | 7.0 million USD | 93.0 million USD |
| 1992Q1 | 7.7 million USD | 92.9 million USD |
| 1991Q4 | ? USD | 82.7 million USD |
| 1991Q3 | ? USD | 78.7 million USD |
| 1991Q2 | ? USD | 77.8 million USD |
| 1991Q1 | ? USD | 87.3 million USD |
| 1990Q4 | ? USD | 139.9 million USD |
| 1990Q3 | ? USD | 62.6 million USD |
| 1990Q2 | ? USD | 69.6 million USD |
| 1990Q1 | ? USD | 65.7 million USD |
| 1989Q4 | ? USD | 85.3 million USD |
| 1989Q3 | ? USD | 63.8 million USD |
| 1989Q2 | ? USD | 68.8 million USD |
| 1989Q1 | ? USD | 68.2 million USD |
| 1988Q4 | ? USD | 66.4 million USD |
| 1988Q3 | ? USD | 46.6 million USD |
| 1988Q2 | ? USD | 50.1 million USD |
| 1988Q1 | ? USD | 50.0 million USD |
| 1987Q3 | ? USD | 28.5 million USD |
| 1987Q2 | ? USD | 26.4 million USD |
| 1987Q1 | ? USD | 34.9 million USD |
| 1986Q4 | ? USD | 34.9 million USD |
| 1986Q3 | ? USD | 34.9 million USD |
| 1986Q2 | ? USD | 34.9 million USD |
| 1986Q1 | ? USD | 22.8 million USD |
| 1985Q4 | ? USD | 22.8 million USD |
| 1985Q3 | ? USD | 22.8 million USD |
TEVA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -559.0 million USD | 15.8 billion USD |
| 2022 | -2.4 billion USD | 14.9 billion USD |
| 2021 | 417.0 million USD | 15.9 billion USD |
| 2020 | -4.0 billion USD | 16.7 billion USD |
| 2019 | -999.0 million USD | 16.9 billion USD |
| 2018 | -2.2 billion USD | 18.9 billion USD |
| 2017 | -16.3 billion USD | 22.4 billion USD |
| 2016 | 329.0 million USD | 21.9 billion USD |
| 2015 | 1.6 billion USD | 19.7 billion USD |
| 2014 | 3.1 billion USD | 20.3 billion USD |
| 2013 | 1.3 billion USD | 20.3 billion USD |
| 2012 | 2.0 billion USD | 20.3 billion USD |
| 2011 | 2.8 billion USD | 18.3 billion USD |
| 2010 | 3.3 billion USD | 16.1 billion USD |
| 2009 | 2.0 billion USD | 13.9 billion USD |
| 2008 | 635.0 million USD | 11.1 billion USD |
| 2007 | 2.0 billion USD | 9.4 billion USD |
| 2006 | 546.0 million USD | 8.4 billion USD |
| 2005 | 1.1 billion USD | 5.3 billion USD |
| 2004 | 331.8 million USD | 4.8 billion USD |
| 2003 | 691.0 million USD | 3.3 billion USD |
| 2002 | 410.3 million USD | 2.5 billion USD |
| 2001 | 278.2 million USD | 2.1 billion USD |
| 2000 | 148.4 million USD | 1.7 billion USD |
| 1999 | 117.8 million USD | 1.3 billion USD |
| 1998 | 68.8 million USD | 1.1 billion USD |
| 1997 | 101.5 million USD | 1.1 billion USD |
| 1996 | 73.4 million USD | 953.8 million USD |
| 1995 | 79.8 million USD | 667.7 million USD |
| 1994 | 71.6 million USD | 587.7 million USD |
| 1993 | 57.5 million USD | 502.0 million USD |
| 1992 | 32.6 million USD | 406.7 million USD |
| 1991 | 23.7 million USD | 327.1 million USD |
| 1990 | 20.8 million USD | 329.0 million USD |
| 1989 | 16.9 million USD | 281.1 million USD |
| 1988 | 12.0 million USD | 211.1 million USD |
| 1986 | 14.8 million USD | 139.6 million USD |
| 1985 | 7.6 million USD | 91.2 million USD |
TEVA
Price: $13.95
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.50 USD
P/E Ratio: -24.76
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 6.4 million
Ebitda: -12.5 billionMarket Capitalization: 15.9 billion
Average Dividend Frequency: 4